[Vaccination against coronavirus disease 2019 (COVID-19)]
Article
[키워드] acute respiratory syndrome
adenoviral vector vaccine
Adults
age
antibodies, neutralizing
approval
booster vaccination
Clinical efficacy
Concentration
coronavirus
coronavirus disease
Course
declined
English
Europe
groups
heterogeneous
Hospitalization
immunogenicity
immunogenicity, vaccine
increase
Infection
mRNA vaccines
National
neutralizing antibody
New
Older
omicron
original virus strain
Patient
recommendation
recommendations
reduced
risk
Risk factors
SARS-CoV‑2
SARS-CoV‑2 variants
severe disease
tested
Trial
Vaccination recommendations
Vaccinations
Vaccine
vaccine dose
Vaccines
variant
viral evolution
virus variant
virus variants
[DOI] 10.1007/s00391-022-02102-x PMC 바로가기
[DOI] 10.1007/s00391-022-02102-x PMC 바로가기